Mark Goldsmith, CEO of Revolution Medicines, has announced the upcoming submission of daraxonrasib for FDA approval as the company begins shipping the experimental drug.
A recent study of children's remains from Camino del Molino, Spain, suggests that respiratory infections, potentially tuberculosis, affected young individuals nearly 5,000 years ago.
President Trump expresses his intention to remain patient as he seeks a significant agreement with Iran, amidst ongoing efforts to resolve tensions between Washington and Tehran.
Recent research suggests that caffeine could mitigate memory issues linked to sleep deprivation by restoring neural communication.
Replimune is set to make a third attempt for FDA approval of its drug, while Pfizer has recently secured a deal in China, highlighting ongoing developments in the pharmaceutical sector.
In a significant shift for Allogene, CEO David Chang is stepping down. This news comes alongside Pfizer's major investment in Chinese pharmaceuticals and WHO's efforts in response to the Ebola outbreak.
As the Ebola outbreak continues to grow, the World Health Organization is engaged in discussions regarding which vaccines may be effective in curbing the spread.
A weight-loss doctor expresses concerns regarding the long-term effects of using small doses of GLP-1 medications for cosmetic weight loss, highlighting the uncertainty surrounding their safety.
Research from LMU biologists shows that plants can tolerate errors in protein synthesis, challenging long-held beliefs about cellular functions and offering new insights into plant biology.
The relationship between wealth and health is critical, influencing how long individuals live. Understanding this connection is essential in addressing economic inequality.
France has recorded its hottest May day ever, contributing to a broader heat wave affecting Europe and prompting health warnings.
A recent study by researchers at University Medical Center Göttingen and the Max Planck Institute sheds light on the regulation of protein synthesis in mitochondria, with potential implications for understanding mitochondrial diseases.
Questions remain about the implications of Trump's Most Favored Nation deals with pharmaceutical companies, as scrutiny increases.
A recent report emphasizes the necessity for local authority inspectors to receive clearer guidance and enhanced support to ensure the welfare of dogs in breeding environments.
As the ASCO conference approaches, attention is drawn to pancreatic cancer developments, alongside significant biotech advancements including GSK's hepatitis B drug.
The market is seeing an influx of wearables claiming to measure blood pressure without validation, a trend that follows the FDA's recent easing of regulations on wellness devices.
A recent hantavirus outbreak tied to a Dutch cruise ship has led to the resurgence of false health claims, echoing patterns seen during previous health crises.
This analysis explores the affordability of health care costs for Medicare recipients, including younger adults with long-term disabilities, based on various data sources.
As states gear up to implement Medicaid work requirements, an issue brief outlines critical policy decisions and challenges that may arise during this process.
The FDA has postponed its decision on AstraZeneca's experimental breast cancer pill after an advisory panel voted against its approval, signaling further review is needed.